Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael D. Roth, MD
University of California, Los Angeles
Principal Investigator - Robert M. Elashoff, PhD
UCLA School of Public Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- David Geffen School of Medicine at Ucla
Los Angeles, California, United States
- University of California, San Francisco
San Francisco, California, United States
- National Jewish Health
Denver, Colorado, United States
- Georgetown University School of Medicine
Washington D.C., District of Columbia, United States
- Feinberg School of Medicine, Northwestern University
Chicago, Illinois, United States
- University of Illinois at Chicago, College of Medicine
Chicago, Illinois, United States
- Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
- Boston University School of Medicine
Boston, Massachusetts, United States
- University of Michigan Medical School
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas Medical School at Houston
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2009
- Primary completion
- 31 Jan 2015
- Completion
- 30 Nov 2015
- Last update posted
- 10 Feb 2017
- Registered enrollment
- 142
- Registry id
- NCT00883129
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.